Literature DB >> 32394672

The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology.

Giuseppe Micali1, Maria L Musumeci2, Ketty Peris3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32394672     DOI: 10.23736/S0392-0488.20.06670-5

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


× No keyword cloud information.
  4 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol.

Authors:  Nicola Silvestris; Valeria Belleudi; Antonio Addis; Fulvia Pimpinelli; Aldo Morrone; Salvatore Sciacchitano; Rita Mancini; Vito Michele Garrisi; Massimo Costantini; Gennaro Ciliberto; Vincenza Frisardi; Giulia Piaggio
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies.

Authors:  Andrea Conti; Giovanni Damiani; Roberta Ruggeri; Giulia Odorici; Francesca Farnetani; Paolo Daniele Maria Pigatto; Giovanni Pellacani
Journal:  Dermatol Ther       Date:  2021-08-16       Impact factor: 3.858

4.  Changing trends in dermatology practice during COVID-19 pandemic: A single tertiary center experience.

Authors:  Efsun Tanacan; Gulhan Aksoy Sarac; Mehmet Ali Can Emeksiz; Didem Dincer Rota; Fatma Gulru Erdogan
Journal:  Dermatol Ther       Date:  2020-09-06       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.